Home > Newsletters > FDAnews Drug Daily Bulletin > FDA Investigates Global Recall System as Part of International Pivot
FDAnews Drug Daily Bulletin
Nov. 1, 2012 | Vol. 9 No. 215
FDA Investigates Global Recall System as Part of International Pivot
The FDA’s Office of International Programs (OIP) is exploring development of a single, global recall system that would encompass all domestic and international recalls. The move toward a global system, currently in its early stages, would help address fast-growing gaps in global oversight of international product recalls, Mark Roh, regional food and drug director for the FDA’s Pacific Region, said.
Drug Industry Daily
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.